.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Camelia Monoranu

Weitere Beteiligungen

27.10.2022
14:00 – 14:10 7 Min. 3 Min.
Abstractvortrag
Pharmaceutical Screening in a ex vivo tumor slice model for vestibular schwannoma
27.10.2022
14:20 – 14:30 7 Min. 3 Min.
Abstractvortrag
Tumormicroenvironment in Vestibular schwannoma with and without NF2
28.10.2022
12:15 – 12:25 7 Min. 3 Min.
Abstractvortrag
Dual CAR-T cell approach in ex vivo glioblastoma models: A new approach to overcome antigen escape mechanisms
29.10.2022
11:30 – 11:40 7 Min. 3 Min.
Abstractvortrag
Pseudoprogression in cases of brain metastases and its neurooncological pitfalls under PD-1 inhibitor therapy in the era of personalized medicine
29.10.2022
11:50 – 12:00 7 Min. 3 Min.
Abstractvortrag
Atypical teratoid rhabdoid tumor in a 24-year-old neurofibromatosis type 1 patient